Expertise in
7
conditions

Dr. Mark Ashamalla

Radiation Oncology
The EHS Cancer Center At The Walsh Ambulatory Pavilion
1920 Brookhaven Ave, 
Far Rockaway, NY 
Expertise in
7
conditions
The EHS Cancer Center At The Walsh Ambulatory Pavilion
1920 Brookhaven Ave, 
Far Rockaway, NY 

Overview

Mark Ashamalla is a Radiation Oncologist practicing medicine in Far Rockaway, New York.

Dr. Ashamalla is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, and Melanoma.

He is actively involved in clinical research, co-authoring 6 peer reviewed articles and participating in 2 clinical trials.

Specialties

Radiation Oncology

Licenses

Radiology in NY

Hospital Affiliations

Suny/stony Brook University Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health First
  • HMO
  • POS
Horizon Healthcare
  • EPO
  • POS
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 2 Less Insurance Carriers -

Locations

The EHS Cancer Center at The Walsh Ambulatory Pavilion
1920 Brookhaven Ave, Far Rockaway, NY 11691

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Randomized Phase III Trial of MEDI4736 (Durvalumab) as Concurrent and Consolidative Therapy or Consolidative Therapy Alone for Unresectable Stage 3 NSCLC
Randomized Phase III Trial of MEDI4736 (Durvalumab) as Concurrent and Consolidative Therapy or Consolidative Therapy Alone for Unresectable Stage 3 NSCLC
Enrollment Status: Active_not_recruiting
Publish Date: June 17, 2026
Intervention Type: Drug, Biological
Study Drugs: Carboplatin, Cisplatin, Durvalumab, Etoposide, Paclitaxel, Pemetrexed Disodium
Study Phase: Phase 3
Randomized Phase II/III Trial of Radiation With Cisplatin at 100 mg/m2 Every Three Weeks Versus Radiation With Weekly Cisplatin at 40 mg/m2 for Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Randomized Phase II/III Trial of Radiation With Cisplatin at 100 mg/m2 Every Three Weeks Versus Radiation With Weekly Cisplatin at 40 mg/m2 for Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Enrollment Status: Suspended
Publish Date: May 07, 2026
Intervention Type: Other, Procedure, Drug, Radiation
Study Drug: Cisplatin
Study Phase: Phase 2/Phase 3
View 1 Less Clinical Trial

6 Total Publications

Lung cancer in nonsmokers- A risk factor analysis.
Lung cancer in nonsmokers- A risk factor analysis.
Journal: Cancer epidemiology
Published: May 19, 2023
Similar Doctors
Expertise in
17
conditions
Dr. Andreas Rimner
Radiation Oncology
Expertise in
17
conditions
Dr. Andreas Rimner
Radiation Oncology
Referral may be required

Memorial Sloan Kettering Cancer Center

1275 York Ave, 
New York, NY 
 (13.9 miles away)
212-639-2000
Languages Spoken:
English

Andreas Rimner is a Radiation Oncologist practicing medicine in New York, New York. Dr. Rimner is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Mesothelioma, Tissue Biopsy, and Thymectomy.

Expertise in
12
conditions
Dr. Daniel Gomez
Radiation Oncology
Expertise in
12
conditions
Dr. Daniel Gomez
Radiation Oncology
Referral may be required

Memorial Sloan Kettering Cancer Center

1275 York Ave, 
New York, NY 
 (13.9 miles away)
315-275-7348
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Daniel Gomez is a Radiation Oncologist practicing medicine in New York, New York. Dr. Gomez is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Mesothelioma. Dr. Gomez is currently accepting new patients.

Expertise in
54
conditions
Dr. Kaled Alektiar
Radiation Oncology
Expertise in
54
conditions
Dr. Kaled Alektiar
Radiation Oncology
Referral may be required

Memorial Sloan Kettering Cancer Center

1275 York Ave, 
New York, NY 
 (13.9 miles away)
646-582-9491
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Kaled Alektiar is a Radiation Oncologist practicing medicine in New York, New York. Dr. Alektiar is highly rated in 54 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Adult Soft Tissue Sarcoma, Fibrosarcoma, Cervical Cancer, and Lymphadenectomy. Dr. Alektiar is currently accepting new patients.

Frequently Asked Questions about Dr. Mark Ashamalla

How do I make an appointment with Dr. Mark Ashamalla?

You can book an appointment with Dr. Mark Ashamalla by calling their office at 347-946-3864. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mark Ashamalla a top-rated expert for Pleuropulmonary Blastoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mark Ashamalla is classified as an Advanced expert for Pleuropulmonary Blastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mark Ashamalla specialize in?

While Dr. Mark Ashamalla is a Radiation Oncology, they have specific expertise in Pleuropulmonary Blastoma, Cervical Cancer, and Neuroendocrine Carcinoma of the Cervix. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Mark Ashamalla participate in research or clinical trials?

Yes. Dr. Mark Ashamalla has published 6 articles and abstracts on conditions like Pleuropulmonary Blastoma. You can view a list of Dr. Mark Ashamalla's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Mark Ashamalla accept my insurance?

Dr. Mark Ashamalla accepts most major insurance plans, including Anthem BCBS and Cigna. We recommend calling the office directly at 347-946-3864 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ashamalla's expertise for a condition
ConditionClose
      View All 7 Advanced Conditions
      View All 19 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile